Video Experimental Relacionado
Updated: Feb 23, 2026
06:16
Involving Individuals with Developmental Language Disorder and Their Parents/Carers in Research Priority Setting
Published on: June 6, 2020
4.6K
Acceso de los niños a los medicamentos controlados: lecciones de política, prioridades de intervención y un marco de
Maria-Belen Tarrafeta-Sayas1, Brandon Maser2, Ximena García-Quintero3
1Department of Public Health, Institute of Tropical Medicine, Antwerp, Antwerp Province, Belgium.
The Lancet. Child & adolescent health
|February 21, 2026
Resumen
Los niños en países de bajos ingresos se enfrentan a importantes barreras para acceder a medicamentos esenciales controlados. Este estudio ofrece soluciones políticas y un marco para mejorar el acceso equitativo a estos medicamentos vitales para las poblaciones pediátricas.
Área de la Ciencia:
- Política de salud Política de salud
- Salud Global La salud global.
- Acceso farmacéutico de acceso.
Sus antecedentes:
- Los niños en países de ingresos bajos y medios (LMICs) experimentan desafíos sustanciales para acceder a medicamentos controlados.
- Las barreras existentes para el acceso a la medicina controlada pediátrica requieren intervenciones integrales, impulsadas por políticas, a nivel del sistema.
- Existe una necesidad crítica de investigación sobre estrategias políticas efectivas para abordar esta desigualdad global.
Objetivo del estudio:
- Revisar la orientación política y los recursos para mejorar el acceso a los medicamentos controlados para niños.
- Para resaltar las lecciones de política transferibles de LMICs (Uganda, India, Costa Rica).
- Proponer prioridades de investigación e intervención y un marco para palancas de acción.
Principales métodos:
- Revisión intencional de la orientación y los recursos de políticas relevantes.
- Análisis de las lecciones políticas de tres países de ingresos bajos y medios.
- Síntesis de la literatura y aportaciones de expertos multidisciplinarios.
Principales resultados:
- Se identificaron las principales lecciones de política y las palancas de acción para mejorar el acceso.
- Desarrolló un marco funcional que describe las estrategias para mejorar el acceso a la medicina controlada pediátrica.
- Destacó la importancia de las intervenciones políticas específicas del contexto, a nivel de sistema.
Conclusiones:
- Abordar las desigualdades globales en el acceso a la medicina controlada pediátrica requiere enfoques dirigidos a políticas y a nivel de sistema.
- Las lecciones de políticas transferibles y la orientación de expertos son cruciales para desarrollar intervenciones efectivas.
- El marco propuesto proporciona medidas viables para mejorar el acceso adecuado a los medicamentos controlados para niños.
Videos de Conceptos Relacionados
01:03Drug Control Governance: Regulatory Bodies and Their Impact
612
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
612
01:26Pharmaceutical Poisoning: Potential Scenarios
22
Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
22
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
356
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
356
01:02Prescription, Nonprescription and Orphan Drugs
1.3K
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
1.3K
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
276
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
276
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
302
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
302